ResearcherUniversity of BirminghamActive in the last 2 years

Dipanwita Nath

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111198474. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. Co-author DOI 10.1002/cam4.71775 ↗
Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e31437 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Animesh Acharjee · 2 shared papers, 2024–2026 · strength 0.64
- Paper Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. DOI 10.1002/cam4.71775 ↗
- Paper Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. DOI 10.1016/j.heliyon.2024.e31437 ↗
Shivan Sivakumar · 1 shared paper, 2026 · strength 0.36
- Paper Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. DOI 10.1002/cam4.71775 ↗
Georgios V. Gkoutos · 1 shared paper, 2024 · strength 0.28
- Paper Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. DOI 10.1016/j.heliyon.2024.e31437 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.